Last updated on October 2018

Early ART to Limit Infection and Establishment of Reservoir

Brief description of study

The study is being done to:

  • start ART early in those recently or acutely infected with HIV-1
  • see how starting ART as soon as the infection is found affects the amount of HIV-1 in blood and how well the body fights the HIV-1 infection
  • look at the amount of HIV-1 DNA (genetic material for HIV-1) seen in CD4+ T-cells (infection-fighting cells in blood) after 48 weeks of ART
  • see how early treatment for HIV affects the numbers of HIV-1 infection fighting cells (CD4+ and CD8+ T-cells) in blood

Clinical Study Identifier: NCT02859558

Find a site near you

Start Over

The Miriam Hosp. ACTG CRS (2951)

Providence, RI United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.